Advancing global programmatic management of latent tuberculosis infection for at risk populations Source: Eur Respir J 2016; 47:1327-1330 Year: 2016
TB situation in Bulgaria – epidemiology, TB-HIV co-infection Source: Eur Respir J 2006; 28: Suppl. 50, 16s Year: 2006
The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results Source: Eur Respir J 2011; 38: 1374-1381 Year: 2011
Clinical – immunological analyse revealing tuberculosis among the people with HIV infection in Armenia Source: Annual Congress 2008 - Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups Year: 2008
Mutual impact of HIV infection on HIV/tuberculosis co-infection Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009
Tuberculosis and HIV co-infection: do we have a surveillance system in Europe? Source: Eur Respir J 2011; 38: 1258-1260 Year: 2011
Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection Source: Eur Respir J 2010; 36: 1242-1247 Year: 2010
Treatment outcomes of MDR-TB and HIV co-infection in Europe Source: Eur Respir J, 49 (6) 1602363; 10.1183/13993003.02363-2016 Year: 2017
The impact of HIV on tuberculosis recrudescence Source: Eur Respir J 2004; 24: Suppl. 48, 362s Year: 2004
Insight into the impact of the COVID-19 epidemic on tuberculosis burden in China Source: Eur Respir J, 56 (3) 2002710; 10.1183/13993003.02710-2020 Year: 2020
Closing the gap in surveillance of tuberculosis and HIV co-infection: a European perspective on the need for clinician–public health alliances Source: Eur Respir J, 50 (5) 1701758; 10.1183/13993003.01758-2017 Year: 2017
How contagious are the new viruses and how can you protect yourself? Source: Annual Congress 2005 - Major viral threats to the lung Year: 2005
The epidemiological significance of TB infection Source: Eur Respir J 2001; 18: Suppl. 33, 144s Year: 2001
European framework to decrease the burden of TB/HIV Source: Eur Respir J 2004; 24: 493-501 Year: 2004
Decreasing cost effectiveness of testing for latent TB in HIV in a low TB incidence area Source: Eur Respir J 2015; 46: 165-174 Year: 2015
Closing the gap in surveillance of tuberculosis and HIV co-infection, and the need for clinician–public health alliances Source: Eur Respir J, 51 (3) 1702671; 10.1183/13993003.02671-2017 Year: 2018